Cargando…
Amelioration of Alzheimer’s disease pathology and cognitive deficits by immunomodulatory agents in animal models of Alzheimer’s disease
The most common age-related neurodegenerative disease is Alzheimer’s disease (AD) characterized by aggregated amyloid-β (Aβ) peptides in extracellular plaques and aggregated hyperphosphorylated tau protein in intraneuronal neurofibrillary tangles, together with loss of cholinergic neurons, synaptic...
Autores principales: | Martinez, Bridget, Peplow, Philip V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425849/ https://www.ncbi.nlm.nih.gov/pubmed/30804241 http://dx.doi.org/10.4103/1673-5374.251192 |
Ejemplares similares
-
Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
por: Martinez, Bridget, et al.
Publicado: (2018) -
MicroRNAs as diagnostic and therapeutic tools for Alzheimer’s disease: advances and limitations
por: Martinez, Bridget, et al.
Publicado: (2019) -
MicroRNA biomarkers in frontotemporal dementia and to distinguish from Alzheimer's disease and amyotrophic lateral sclerosis
por: Martinez, Bridget, et al.
Publicado: (2021) -
STAT3 ameliorates cognitive deficits via regulation of NMDAR expression in an Alzheimer's disease animal model
por: Wan, Hua-Li, et al.
Publicado: (2021) -
Curcuminoid submicron particle ameliorates cognitive deficits and decreases amyloid pathology in Alzheimer’s disease mouse model
por: Tai, Yi-Heng, et al.
Publicado: (2018)